Trial intelligence / Profile preview

Arnebia euchroma vaginal cream versus clotrimazole for candida vulvovaginitis

IRCT20190303042889N2Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of clotrimazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Presence of infection, Hypersensitivity and 6 more. Started Apr 2017; status: completed.

02

Drugs

clotrimazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on IRCT20190303042889N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190303042889N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call